HGH (Recombinant/Liquid) 33.3 mg (100 IU) – US Stock

HGH (Recombinant/Liquid) from Hilma Biocare is a recombinant human growth hormone formulation containing Human Growth Hormone (HGH) as its active ingredient. The product is supplied in liquid form as five 2 ml vials, providing a total labeled quantity of 33.3 mg (100 IU).

Product Overview

Human Growth Hormone, also known as somatropin, is a peptide hormone consisting of a 191-amino-acid polypeptide. The supplied product description identifies this formulation as recombinant HGH and describes it as structurally identical to naturally produced human growth hormone.

The product specifications classify HGH as a peptide hormone supplied in an injectable format. The stated active half-life is approximately 2–3 hours. The specifications also identify water retention as present and aromatization as absent.

Active Ingredient

The active ingredient is Human Growth Hormone (HGH), also referred to as recombinant somatropin in the supplied product information.

Strength and Presentation

The product is labeled as 33.3 mg (100 IU) and is supplied as 5 × 2 ml vials, for a total product volume of 10 ml.

Product Characteristics

According to the supplied specifications, this HGH formulation has the following characteristics:

• Recombinant human growth hormone
• 191-amino-acid polypeptide
• Peptide hormone classification
• Liquid formulation
• Injectable presentation
• 33.3 mg (100 IU) total labeled quantity
• 5 × 2 ml vials
• Approximately 2–3-hour active half-life
• Water retention listed as present
• Aromatization listed as absent

Product Specifications

Product Characteristics

Recombinant human growth hormone is a peptide hormone composed of 191 amino acids. The supplied description explains that HGH is involved in physiological processes including protein metabolism, amino-acid transport, collagen synthesis, and regulation of blood glucose.

The source material also describes HGH in connection with nutrient utilization involving nitrogen, phosphorus, calcium, and sodium. These descriptions identify physiological characteristics of the hormone and should not be interpreted as guarantees of specific physical, athletic, or cosmetic outcomes.

Reported Side Effects

The supplied product information identifies several potential adverse effects associated with HGH, including:

• Elevated LDL cholesterol levels
• Joint pain
• Organ growth
• Tunnel vision
• Limb numbness

Because recombinant human growth hormone is a biologically active peptide hormone, appropriate medical evaluation and professional supervision are important when considering its use.

Important Information

HGH is a pharmacologically active hormone and is not presented here as a general nutritional supplement or performance-enhancement recommendation. The information on this page is provided for product identification and factual specification purposes only and does not constitute personalized medical advice.

No dosage recommendations, treatment protocols, injection instructions, stacking regimens, or instructions for self-administration are provided. The supplied source contains references to athletic use and combining HGH with other compounds; those claims have not been presented as recommendations.

About Hilma Biocare USA

HGH (Recombinant/Liquid) 33.3 mg (100 IU) is part of the Hilma Biocare product range. The product is presented as a liquid recombinant human growth hormone formulation containing a total labeled quantity of 33.3 mg (100 IU) and supplied in five 2 ml vials as US Stock.